Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition. - Wikidata - awgldk - TriplyDB

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

http://www.wikidata.org/entity/Q38776860

about

Genetically engineered mouse models in oncology research and cancer medicine The transcriptome of lung tumor-infiltrating dendritic cells reveals a tumor-supporting phenotype and a microRNA signature with negative impact on clinical outcome A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016 TLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking.The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses.TRAF6 regulates the effects of polarized maturation of tolerability: Marrow-derived dendritic cells on collagen-induced arthritis in mice.The importance for immunoregulation for long-term cancer control.A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model.Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies.Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.Molecular mechanisms involved in dendritic cell dysfunction in cancer.The role of dendritic cells in cancer.DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses Dendritic cells in cancer: the role revisited.Functions of Murine Dendritic Cells.Dendritic Cells and Cancer Immunity.The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.Applying Mass Cytometry to the Analysis of Lymphoid Populations in Transplantation.Innate immune signaling and regulation in cancer immunotherapy.Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally.Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues.TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy.Mechanisms of Resistance to Immune Checkpoint Antibodies.Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccines Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines.Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells.Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells.Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells.Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response.Antigen Cross-Presentation and T-Cell Cross-Priming In Cancer Immunology And Immunotherapy.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity.Strategies to Improve the Efficacy of Dendritic Cell-Based Immunotherapy for Melanoma.Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity.Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies.Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.

P2860

Q28079323-A4869DD0-6AE9-4B4A-AA9B-A2322335EAF6 Q29248715-21E264EB-C024-42F6-9D84-481E8A7C15BB Q33615407-133DD4A4-FF64-405E-80EE-5D5544B8277B Q33814908-BB0923E3-2C1B-45A2-91B1-ECFD133384C7 Q36212034-99A6C03A-E756-45B2-9B61-7AF571CE1F90 Q37541609-0D05BEF2-F1E0-46E0-8C6E-64F36C85F65B Q37554718-D2DA3B0A-3F30-4B5C-BC14-9537CE3DD0ED Q37701080-F50C7654-7FC8-48E9-B12E-9FCEAE886DCE Q38647002-8FF3BC4B-20CD-4DFB-8940-2907AA317BB5 Q38675900-A339A2EF-97AD-4722-B41E-E524F99B632B Q38704192-63A932F3-FE7C-4277-9C37-9E413E25A3B2 Q38874383-076F839E-31C1-4674-954E-CDC7A6B81025 Q38916367-45B3F01E-65A3-4F95-A59E-E466F8AC5BC6 Q38918609-260CDC8A-D0D2-4CD3-ACD1-E4E7867A98BB Q38957065-82ABEE72-E509-4823-AFBB-9D5A96AF9DC9 Q38957582-305DE56F-6621-499B-8585-B0E399A72CDA Q38963934-86038E93-F447-4776-997D-BA5B64E93401 Q38985483-4C22B89B-9BB7-4E09-B313-5C7FE3651E25 Q38994017-0AE3A27C-6C4C-4D01-8261-BF939A8B800D Q39020369-46B6B059-7583-4EB9-8998-FC07BD582E53 Q39020480-A371879F-4D8D-4E55-8D9A-999FB0AF8BB0 Q39041026-070260C2-132B-4782-84A9-DC7236A45FB0 Q39043844-EBE9C47B-D1DD-4308-A08A-F518CD91BB82 Q39136220-E0D3E38B-2A99-4952-80EB-71BC645BA158 Q39160959-E74EAA67-B9F3-4B96-B526-2E1DB6845198 Q39185608-9D34F281-EA84-442B-BAD2-3687BA9AB3EF Q39243064-F59D7C3A-AE66-41B4-8EAA-0EB703DBE272 Q39448911-A2A2E42D-D579-4239-A35E-04AA57953182 Q39450802-9EB36CD6-E876-46EA-AFD6-D714D6009085 Q40099497-8AD4C69F-0F42-4AA7-8FFA-586F69D170D3 Q40120388-9FFAD11A-B153-4696-881C-2CF712B7572D Q41526747-1C66A13F-B49C-4A22-B68C-7337DA03BDB3 Q41718028-20CC3CE9-FC3F-4907-81C1-1423ACC5780F Q41930681-2B1FBCDA-34B5-4243-88E8-8789DDB7B831 Q42378527-9B5769A4-E9F1-4D10-85A5-CD72CCC5EDE0 Q46909626-1072A951-384A-49A3-B2B6-6995EACEEC1D Q47135720-F763BC3D-466A-4792-8558-0E813BBCD971 Q47381391-A9A7BDFF-3311-40E4-BAAA-6BBF3B707E29 Q47557087-2A0C884E-BD98-42AE-8374-1DAB9B9EE0D1 Q47571709-46C20A44-B06F-4790-BA51-AEE05F8D21DC

P2860

Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.

http://www.wikidata.org/entity/Q38776860

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Expansion and Activation of CD ...... tic PD-L1 and BRAF Inhibition.

@en

type

label

Expansion and Activation of CD ...... tic PD-L1 and BRAF Inhibition.

@en

prefLabel

Expansion and Activation of CD ...... tic PD-L1 and BRAF Inhibition.

@en

P1433

Q38776860-8FEE58AB-41AC-4E49-84B7-EFAB3893E104

P1476

Q38776860-101A6E5B-7AFC-4277-8E3E-714348602D72

P2093

Q38776860-01F118D6-DDB8-4BE1-9111-370DD41623A3

Q38776860-0317BCDA-5766-4A6F-85B7-7B961C40F3CD

Q38776860-0FD599BD-40F5-4F55-9383-E7CAA0EE7E62

Q38776860-1DFDF0A4-ABAC-44D9-B596-64AADE0DD7E9

Q38776860-27B2FEAE-7177-4E86-86F1-9B1494E06B7A

Q38776860-27C0D212-BD13-4B28-A33A-4DCE6D5C40BC

Q38776860-289EDF3B-C072-45E1-9463-1BA0E967B788

Q38776860-4DC1540A-8A95-4576-9737-CEAAAD6FC46A

Q38776860-7EFB37FD-9594-4231-9A1A-4D8EF81E354B

Q38776860-802FDCA8-B9B6-4200-AB48-200C7879B737

P2860

Q38776860-0096D4CC-9083-4589-BEA9-38C5EF1EAF5F

Q38776860-0CE17F0F-B740-40C4-A738-9F56312DD947

Q38776860-10780D7C-7DE4-446D-A1E2-A180E97E96E5

Q38776860-147B5CE8-3040-4F84-8E4A-F8460A95CA5F

Q38776860-148B420D-4CC1-4A16-873B-02C28169DA6C

Q38776860-1850063B-74F5-4C7F-9907-50ABBFDBEB59

Q38776860-185F7731-0601-4824-8600-55C4E90F22B7

Q38776860-1BE46CA3-7021-4BB1-B6F7-5611A9736A73

Q38776860-21CC9EE6-5FB0-48BD-ABDE-58FE21D43A66

Q38776860-2207FFC1-CD3B-49F2-8118-C081D92A66C8

P304

Q38776860-01B1CC62-E0FC-4B71-8506-D1E14EA81F94

P31

Q38776860-2FD4204F-23FA-467E-AC2C-41AF83A3C48F

P356

Q38776860-6F493C00-0F8C-42AD-B985-62BCAD2D0899

P407

Q38776860-7C715B12-A250-457D-A999-3D210044BC44

P433

Q38776860-B6C404DA-3BC4-4CAB-AB6C-3E0334CE7D34

P478

Q38776860-61ED9598-F4E5-4292-94F1-0B66E22B59BE

P50

Q38776860-1A053776-EDB1-4B4D-9916-BCE74242A82E

Q38776860-4D010700-0488-4DA6-B5A2-D6FDF3AF498B

Q38776860-979047EB-A1EC-4A5A-9CF6-F2FC5CB62739

Q38776860-A7F3A2B0-276C-4EFE-8CCA-41DC4E8E06A6

P577

Q38776860-F63680C2-6678-4BB0-AA40-F3B704D3714F

P698

Q38776860-FD62CD68-3643-4B15-B999-118A3FFE1B75

P932

Q38776860-36B38508-247C-4DFC-AD09-D868F05F3921

P356

J.IMMUNI.2016.03.012

P1433

P1476

Expansion and Activation of CD ...... utic PD-L1 and BRAF Inhibition

@en

P2093

Adeeb Rahman

http://www.w3.org/2001/XMLSchema#string

Anna Karolina Palucka

http://www.w3.org/2001/XMLSchema#string

Brandon Hogstad

http://www.w3.org/2001/XMLSchema#string

Brian D Brown

http://www.w3.org/2001/XMLSchema#string

Christina Rivera

http://www.w3.org/2001/XMLSchema#string

Florent Ginhoux

http://www.w3.org/2001/XMLSchema#string

Hélène Salmon

http://www.w3.org/2001/XMLSchema#string

Joshua Brody

http://www.w3.org/2001/XMLSchema#string

Judith Agudo

http://www.w3.org/2001/XMLSchema#string

Juliana Idoyaga

http://www.w3.org/2001/XMLSchema#string

P2860

Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

PD-1 and its ligands in tolerance and immunity

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

The future of immune checkpoint therapy

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

P304

924-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2016.03.012

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Daigo Hashimoto

Svetoslav Chakarov

María Casanova-Acebes

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27096321

http://www.w3.org/2001/XMLSchema#string

P932

4980762

http://www.w3.org/2001/XMLSchema#string